Journal of Clinical Oncology

The Journal of Clinical Oncology (JCO) is a medical journal published 3 times a month (36 issues a year) by the American Society of Clinical Oncology (ASCO), with a 2010 impact factor of 18.970. JCO now accounts for nearly one in 10 of all oncology journal citations. This journal s focus is work that relates to the care of patients with cancer, e.g., clinical oncology. This journal publishes in varying formats. Original research reports are both a communication tool and reports for original research. Review articles can describe work that builds on previous original research, summarize the current state clinical oncology, or can be a point of critical analysis. Opinion is voiced in editorial formats, which include commentary and discuss controversies. There is also a format for perspectives from a person of public notoriety. Special articles are another form of communication besides original research reports, which promulgate guidelines, summaries of consensus, and other scholarly communications. Fundamental research is covered in the "Biology of Neoplasia" section.

American Society of Clinical Oncology
Impact factor
18.372 (2011)
Some content from Wikipedia, licensed under CC BY-SA

Research reveals artificial thyroid cancer epidemic

Research led by The Australian National University (ANU) has found doctors around the world are over diagnosing the most common thyroid cancer, creating an artificial epidemic that costs billions of dollars each year in unnecessary ...

Sep 06, 2016
popularity107 comments 0

Enoxaparin prevents VTEs in advanced pancreatic cancer

(HealthDay)—For patients with advanced pancreatic cancer (APC), enoxaparin is effective for prevention and treatment of venous thromboembolic events (VTEs), according to a study published online May 18 in the Journal of ...

May 20, 2015
popularity7 comments 0

PSA failure predicts risk of death only in healthy men

A new study by investigators at Brigham and Women's Hospital (BWH) has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated ...

Sep 06, 2016
popularity2 comments 0

Obesity linked to improved survival in kidney cancer

Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival ...

Sep 05, 2016
popularity2 comments 0